Logo image of INVX

INNOVEX INTERNATIONAL INC (INVX) Stock Fundamental Analysis

USA - NYSE:INVX - US4576511079 - Common Stock

16.91 USD
-0.44 (-2.54%)
Last: 9/17/2025, 8:04:01 PM
23.6 USD
+6.69 (+39.56%)
After Hours: 9/17/2025, 8:04:01 PM
Fundamental Rating

7

Overall INVX gets a fundamental rating of 7 out of 10. We evaluated INVX against 61 industry peers in the Energy Equipment & Services industry. INVX is in great health and has no worries on liquidiy or solvency at all, but the profibility rating is only average. INVX is not priced too expensively while it is growing strongly. Keep and eye on this one! With these ratings, INVX could be worth investigating further for growth investing!.


Dividend Valuation Growth Profitability Health

Quickly go to:

6

1. Profitability

1.1 Basic Checks

INVX had positive earnings in the past year.
INVX had a positive operating cash flow in the past year.
In multiple years INVX reported negative net income over the last 5 years.
The reported operating cash flow has been mixed in the past 5 years: INVX reported negative operating cash flow in multiple years.
INVX Yearly Net Income VS EBIT VS OCF VS FCFINVX Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M -100M 200M

1.2 Ratios

INVX has a better Return On Assets (11.77%) than 95.08% of its industry peers.
Looking at the Return On Equity, with a value of 14.51%, INVX is in the better half of the industry, outperforming 77.05% of the companies in the same industry.
INVX has a better Return On Invested Capital (7.20%) than 62.30% of its industry peers.
Industry RankSector Rank
ROA 11.77%
ROE 14.51%
ROIC 7.2%
ROA(3y)3.87%
ROA(5y)-0.76%
ROE(3y)4.84%
ROE(5y)-0.55%
ROIC(3y)N/A
ROIC(5y)N/A
INVX Yearly ROA, ROE, ROICINVX Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5 -5 10 -10

1.3 Margins

The Profit Margin of INVX (16.66%) is better than 91.80% of its industry peers.
In the last couple of years the Profit Margin of INVX has grown nicely.
INVX has a better Operating Margin (11.37%) than 63.93% of its industry peers.
In the last couple of years the Operating Margin of INVX has grown nicely.
INVX has a Gross Margin of 32.96%. This is in the better half of the industry: INVX outperforms 65.57% of its industry peers.
In the last couple of years the Gross Margin of INVX has grown nicely.
Industry RankSector Rank
OM 11.37%
PM (TTM) 16.66%
GM 32.96%
OM growth 3YN/A
OM growth 5Y64.81%
PM growth 3YN/A
PM growth 5Y120.24%
GM growth 3Y12.33%
GM growth 5Y4.04%
INVX Yearly Profit, Operating, Gross MarginsINVX Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40

More info and screens

8

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), INVX is destroying value.
The number of shares outstanding for INVX has been increased compared to 1 year ago.
INVX has more shares outstanding than it did 5 years ago.
Compared to 1 year ago, INVX has a worse debt to assets ratio.
INVX Yearly Shares OutstandingINVX Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M
INVX Yearly Total Debt VS Total AssetsINVX Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B

2.2 Solvency

An Altman-Z score of 4.76 indicates that INVX is not in any danger for bankruptcy at the moment.
With an excellent Altman-Z score value of 4.76, INVX belongs to the best of the industry, outperforming 95.08% of the companies in the same industry.
INVX has a debt to FCF ratio of 0.23. This is a very positive value and a sign of high solvency as it would only need 0.23 years to pay back of all of its debts.
INVX has a Debt to FCF ratio of 0.23. This is amongst the best in the industry. INVX outperforms 93.44% of its industry peers.
A Debt/Equity ratio of 0.03 indicates that INVX is not too dependend on debt financing.
INVX's Debt to Equity ratio of 0.03 is amongst the best of the industry. INVX outperforms 86.89% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.03
Debt/FCF 0.23
Altman-Z 4.76
ROIC/WACC0.83
WACC8.72%
INVX Yearly LT Debt VS Equity VS FCFINVX Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500M 1B

2.3 Liquidity

A Current Ratio of 4.60 indicates that INVX has no problem at all paying its short term obligations.
The Current ratio of INVX (4.60) is better than 91.80% of its industry peers.
INVX has a Quick Ratio of 2.69. This indicates that INVX is financially healthy and has no problem in meeting its short term obligations.
Looking at the Quick ratio, with a value of 2.69, INVX belongs to the top of the industry, outperforming 88.52% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 4.6
Quick Ratio 2.69
INVX Yearly Current Assets VS Current LiabilitesINVX Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B

More info and screens

9

3. Growth

3.1 Past

INVX shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 204.76%, which is quite impressive.
INVX shows a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 123.23% yearly.
Looking at the last year, INVX shows a very strong growth in Revenue. The Revenue has grown by 41.65%.
Measured over the past years, INVX shows a quite strong growth in Revenue. The Revenue has been growing by 9.76% on average per year.
EPS 1Y (TTM)204.76%
EPS 3YN/A
EPS 5Y123.23%
EPS Q2Q%130%
Revenue 1Y (TTM)41.65%
Revenue growth 3Y27.02%
Revenue growth 5Y9.76%
Sales Q2Q%86.33%

3.2 Future

Based on estimates for the next years, INVX will show a very strong growth in Earnings Per Share. The EPS will grow by 148.21% on average per year.
Based on estimates for the next years, INVX will show a very strong growth in Revenue. The Revenue will grow by 40.16% on average per year.
EPS Next Y493%
EPS Next 2Y148.21%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year93.68%
Revenue Next 2Y40.16%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
INVX Yearly Revenue VS EstimatesINVX Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 200M 400M 600M 800M
INVX Yearly EPS VS EstimatesINVX Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 0 2 4

More info and screens

6

4. Valuation

4.1 Price/Earnings Ratio

INVX is valuated quite expensively with a Price/Earnings ratio of 25.62.
The rest of the industry has a similar Price/Earnings ratio as INVX.
The average S&P500 Price/Earnings ratio is at 27.20. INVX is around the same levels.
INVX is valuated reasonably with a Price/Forward Earnings ratio of 11.95.
INVX's Price/Forward Earnings ratio is a bit cheaper when compared to the industry. INVX is cheaper than 78.69% of the companies in the same industry.
The average S&P500 Price/Forward Earnings ratio is at 22.70. INVX is valued slightly cheaper when compared to this.
Industry RankSector Rank
PE 25.62
Fwd PE 11.95
INVX Price Earnings VS Forward Price EarningsINVX Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, INVX is valued a bit more expensive than 63.93% of the companies in the same industry.
INVX's Price/Free Cash Flow ratio is rather cheap when compared to the industry. INVX is cheaper than 85.25% of the companies in the same industry.
Industry RankSector Rank
P/FCF 6.46
EV/EBITDA 7.61
INVX Per share dataINVX EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10

4.3 Compensation for Growth

INVX's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
INVX has a very decent profitability rating, which may justify a higher PE ratio.
A more expensive valuation may be justified as INVX's earnings are expected to grow with 148.21% in the coming years.
PEG (NY)0.05
PEG (5Y)0.21
EPS Next 2Y148.21%
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

No dividends for INVX!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

INNOVEX INTERNATIONAL INC

NYSE:INVX (9/17/2025, 8:04:01 PM)

After market: 23.6 +6.69 (+39.56%)

16.91

-0.44 (-2.54%)

Chartmill FA Rating
GICS SectorEnergy
GICS IndustryGroupEnergy
GICS IndustryEnergy Equipment & Services
Earnings (Last)08-05 2025-08-05/amc
Earnings (Next)N/A N/A
Inst Owners47.97%
Inst Owner Change4.52%
Ins Owners1.52%
Ins Owner Change5.63%
Market Cap1.16B
Analysts77.78
Price Target18.7 (10.59%)
Short Float %N/A
Short Ratio7.91
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly Dividend1.45
Dividend Growth(5Y)N/A
DP51.9%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-23.38%
Min EPS beat(2)-24.08%
Max EPS beat(2)-22.68%
EPS beat(4)1
Avg EPS beat(4)-40.73%
Min EPS beat(4)-165.36%
Max EPS beat(4)49.19%
EPS beat(8)1
Avg EPS beat(8)-164.95%
EPS beat(12)3
Avg EPS beat(12)-83.38%
EPS beat(16)3
Avg EPS beat(16)-90.25%
Revenue beat(2)1
Avg Revenue beat(2)1.36%
Min Revenue beat(2)-4.42%
Max Revenue beat(2)7.14%
Revenue beat(4)3
Avg Revenue beat(4)5.8%
Min Revenue beat(4)-4.42%
Max Revenue beat(4)10.25%
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)1.85%
PT rev (3m)14.58%
EPS NQ rev (1m)15.02%
EPS NQ rev (3m)15.02%
EPS NY rev (1m)12.06%
EPS NY rev (3m)12.06%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)0.84%
Revenue NY rev (3m)2.19%
Valuation
Industry RankSector Rank
PE 25.62
Fwd PE 11.95
P/S 1.34
P/FCF 6.46
P/OCF 5.9
P/B 1.17
P/tB 1.5
EV/EBITDA 7.61
EPS(TTM)0.66
EY3.9%
EPS(NY)1.41
Fwd EY8.37%
FCF(TTM)2.62
FCFY15.49%
OCF(TTM)2.87
OCFY16.95%
SpS12.61
BVpS14.47
TBVpS11.29
PEG (NY)0.05
PEG (5Y)0.21
Profitability
Industry RankSector Rank
ROA 11.77%
ROE 14.51%
ROCE 9.12%
ROIC 7.2%
ROICexc 7.69%
ROICexgc 9.81%
OM 11.37%
PM (TTM) 16.66%
GM 32.96%
FCFM 20.77%
ROA(3y)3.87%
ROA(5y)-0.76%
ROE(3y)4.84%
ROE(5y)-0.55%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5Y74.94%
ROICexc growth 3YN/A
ROICexc growth 5Y70.29%
OM growth 3YN/A
OM growth 5Y64.81%
PM growth 3YN/A
PM growth 5Y120.24%
GM growth 3Y12.33%
GM growth 5Y4.04%
F-Score6
Asset Turnover0.71
Health
Industry RankSector Rank
Debt/Equity 0.03
Debt/FCF 0.23
Debt/EBITDA 0.23
Cap/Depr 33.62%
Cap/Sales 1.96%
Interest Coverage 250
Cash Conversion 132.1%
Profit Quality 124.67%
Current Ratio 4.6
Quick Ratio 2.69
Altman-Z 4.76
F-Score6
WACC8.72%
ROIC/WACC0.83
Cap/Depr(3y)71.76%
Cap/Depr(5y)56.98%
Cap/Sales(3y)4.99%
Cap/Sales(5y)4.26%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)204.76%
EPS 3YN/A
EPS 5Y123.23%
EPS Q2Q%130%
EPS Next Y493%
EPS Next 2Y148.21%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)41.65%
Revenue growth 3Y27.02%
Revenue growth 5Y9.76%
Sales Q2Q%86.33%
Revenue Next Year93.68%
Revenue Next 2Y40.16%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y81.5%
EBIT growth 3YN/A
EBIT growth 5Y80.9%
EBIT Next Year58.97%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y301.81%
FCF growth 3Y41.07%
FCF growth 5Y90.29%
OCF growth 1Y438.74%
OCF growth 3Y34.47%
OCF growth 5Y44.76%